Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nickel Catalyzed Coupling . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113105374A reveals a nickel-catalyzed method for alkylamine derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Ni-catalyzed desulfitative coupling of sulfonyl chlorides offers high yield and broad scope. A cost-effective route for API intermediates and fine chemicals.
Novel Ni-catalyzed method for trifluoroethylation using cheap 2-chloro-1,1,1-trifluoroethane. Mild conditions, high yield, suitable for pharma intermediates.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Novel nickel-catalyzed method for diaryl ketones. High purity, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN118754905B reveals nickel catalysis for silane synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Patent CN116655467B reveals nickel-catalyzed esterification. Enables cost reduction in pharma intermediate manufacturing with mild conditions and high yield.
Patent CN106146454B details a nickel-catalyzed Negishi coupling method for polyfluorinated biaryls, offering high selectivity and cost-effective manufacturing for fine chemical supply chains.
Patent CN116655529A reveals a nickel-catalyzed route for 3-aryl quinolines, offering mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Novel nickel-catalyzed method offers cost reduction in pharma intermediates manufacturing with scalable one-pot synthesis for high-purity aryl alkenyl sulfoxide.
Patent CN110117237B reveals a mild nickel-catalyzed cyanation method for aromatic nitriles. This technology offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN112724110B details a novel nickel-catalyzed route for VEGFR inhibitor intermediates, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN116283672B introduces a nickel-catalyzed reductive coupling method eliminating Grignard reagents to enhance atom economy and reduce manufacturing costs for high-purity pharmaceutical intermediates.
This patent introduces a nickel-catalyzed method for synthesizing beta-allyl phenethylamine derivatives with atom economy and step efficiency. It enhances supply chain reliability while reducing manufacturing costs through simplified processes for pharmaceutical intermediates.
Patent CN106187656B enables >99% selective monoarylation under mild conditions, reducing costs and lead times for high-purity fine chemicals.
Discover how nickel-catalyzed C-C coupling enables high-yield synthesis of linear olefin benzhydryl piperazine, reducing production costs and supply chain risks for pharmaceutical intermediates.
Solve polyfluoroarene coupling challenges: 99% selectivity, room-temperature operation, and 85-99% yield. Reduce costs and supply chain risks for API intermediates.
Discover how nickel-catalyzed carbon-carbon coupling enables high-yield, cost-effective synthesis of benzhydryl piperazine intermediates for pharmaceuticals, eliminating strict anhydrous conditions and reducing supply chain risks.
Solve high palladium costs & low yields in sartanbiphenyl synthesis. Our nickel-catalyzed method achieves >85% yield, 98% purity, and clean manufacturing. Scale to 100MT/yr.